MARIETTA, Ga.--Jan. 10, 2006--SanuWave Inc., a leading provider of Extracorporeal Shockwave Treatment (ESWT) for heel pain and tennis elbow, announced today that the company has named Christopher M. Cashman as its new Chief Executive Officer, effective immediately. Cashman, 38, is a 14-year veteran of the medical device industry.

Kevin A. Richardson, II, Chairman of the company and Managing Partner of SanuWave's majority owner, Prides Capital Partners LLC, commented on the hiring: "Chris brings strong leadership skills combined with a broad range of experience at well regarded medical device companies. We believe that with this key hire, we have augmented our current corporate staff and further positioned the company to become the premier Extracorporeal Shockwave Treatment (ESWT) provider in the U.S. and abroad.

“With exciting trends driving demand in pain management and cutting-edge sports medicine, Prides is very pleased to maintain a strong level of support and involvement in such a promising company”

"With exciting trends driving demand in pain management and cutting-edge sports medicine, Prides is very pleased to maintain a strong level of support and involvement in such a promising company," Richardson continued. "We look forward to working with Chris as he taps his extensive expertise to lead the company."

"I'm excited to be joining SanuWave at a time when Shockwave technology looks so promising in orthopedics and I look forward to working with this leading technology as we uncover how it may be beneficial in other medical areas," said Cashman.

Most recently, Cashman served as President of Therapeutic Surfaces for Kinetic Concepts, Inc, a global leader in advanced wound care. Prior to that, Cashman conducted a management buyout in November 2001 of Snowden Pencer, a minimally invasive surgical device manufacturer, and assumed the role of CEO and President. In March 2004, Snowden Pencer was sold to Cardinal Health. Cashman has also served as a business unit head with Genzyme Biosurgery and held several senior sales and marketing positions with Genzyme Surgical Products and Deknatel Snowden Pencer.

Cashman graduated from the United States Naval Academy in 1989 with a B.S. in Economics and served on a fast attack submarine as Supply Officer. He received his MBA in 2001 from The Kellogg Graduate School of Management at Northwestern University.

About SanuWave, Inc.

SanuWave, headquartered in Marietta, GA, provides non-invasive surgical solutions for orthopaedic conditions such as chronic plantar fasciitis and chronic lateral epicondylitis, more commonly known as heel pain and tennis elbow, respectively. For more information, please visit www.sanuwave.com.

About Prides Capital Partners, LLC

Prides Capital, based in Boston and San Francisco, specializes in strategic block, active investing in small- and micro-cap public and private companies. In partnership with its management teams, Prides seeks to create value through strategic, operational and financial assistance. For more information visit http://www.pridescapital.com.